Experience

Immunomedics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Scientist, Purification & Analytical Development

  • Jan 2014 - Present

  ▪ Develop, optimize, validate and troubleshoot analytical methods to support development of therapeutic proteins including antibodies, bispecific antibodies and ADCs with technology transfer to quality control group and CMOs ▪ New product evaluation, scale-up, process optimization and the development of purification platforms with technology transfer to downstream manufacturing group ▪ Plan and execute product comparability and stability studies to ensure product and process… Show more ▪ Develop, optimize, validate and troubleshoot analytical methods to support development of therapeutic proteins including antibodies, bispecific antibodies and ADCs with technology transfer to quality control group and CMOs ▪ New product evaluation, scale-up, process optimization and the development of purification platforms with technology transfer to downstream manufacturing group ▪ Plan and execute product comparability and stability studies to ensure product and process consistency ▪ Generate and execute process development protocols, viral clearance protocols, validation reports, new product batch records and standard operating procedures (SOPs) ▪ Write formal analytical reports for inclusion in regulatory filling

• Associate Scientist, Purification & Analytical Development

  • Feb 2011 - Dec 2013

• Team Leader, Downstream Purificaion

  • Jun 2009 - Jan 2011



Mount Sinai Innovation Partners

• United States
• Hospitals and Health Care
• 1 - 100 Employee

• Business Development Intern

  • Oct 2015 - Jun 2016

  ▪ Evaluated commercialization potential of technology assets with a focus on neurology and oncology therapeutics ▪ Examined new technologies from Mount Sinai researchers to determine commercial potential by analyzing existing market, literature, and intellectual property in the biotech industry ▪ Evaluated commercialization potential of technology assets with a focus on neurology and oncology therapeutics ▪ Examined new technologies from Mount Sinai researchers to determine commercial potential by analyzing existing market, literature, and intellectual property in the biotech industry